WHAT'S HOT IN LIFE
#LABLIFE
ABCLONAL
Recent Posts

Webinar Recap: Monoclonal Antibodies in Cancer Therapy

Posted by Dennis Miao on Dec 3, 2020 12:00:00 PM

For the second installment in our ABclonal Webinar Series, we had the privilege of inviting Dr. Clarke Gasper, our Business Development Scientist, to share his insights on the production and development of monoclonal antibodies for cancer therapy. If you were unable to attend the live session or would like to re-watch to review some of Dr. Gasper’s key points, we’ve got you covered with a link to a recording of the webinar and Q&A here, as well as a recap of his lecture below.

 

Necroptosis: The Inflammatory Counterpart of Good Ol’ Apoptosis

Posted by Kashyap Gayathri on Nov 25, 2020 5:27:12 PM

A Bird’s Eye View of Necroptosis

Necroptosis is a type of regulated necrotic death driven by defined molecular pathways. Regulated necrosis regulates programmed cell death. Necroptosis is at the center of the pathophysiology of several clinically-relevant disease states, including myocardial infarction and stroke, atherosclerosis, ischemia-reperfusion injury, pancreatitis, and inflammatory bowel disease. Necroptosis results in necrosis-like morphological changes, such as cell swelling, plasma membrane pore formation, and membrane rupture. It also requires co-activation of receptor-interacting protein (RIP) 1 and RIP3 kinases. Necrosome is a complex formed by RIP1, RIP3 and Fas-associated proteins with death domain (FADD). Several studies in the preclinical stage have demonstrated that targeting necrosome can have variable effects on progression of tumors, indicating that it is largely cell-type or context dependent.

Autophagy: A Natural Detox

Posted by Kashyap Gayathri on Nov 18, 2020 3:00:00 PM

Autophagy can be understood as ‘self-eating’. In simple terms, it is a vitally important cleansing mechanism carried out by the cells in our body. It brings about the degradation of the cytoplasmic contents within membrane bound vesicles called lysosomes.

 

Ferroptosis as a New Type of Inflammatory Programmed Cell Death

Posted by Bryent Lee on Nov 12, 2020 1:00:00 PM

When it comes to programmed cell death (PCD), apoptosis is usually the first process that comes to mind. However, there is a new type of inflammatory PCD discovered in 2012, known as ferroptosis, that is genetically and biochemically distinct from other PCD.1

 

Antibodies Served With a Side of Phospho-Specificity

Posted by Kashyap Gayathri on Nov 11, 2020 12:00:00 PM

Anyone who is remotely interested in biology, or has perhaps scrolled through fitness websites to get in shape, has come across the word "protein". There is, however, much more to proteins than simply being a key player in maintaining active lifestyles. Proteins are ubiquitous in the cells of the body and are the driving force for key cellular processes. In order for proteins to carry out their duties, they need to be well-armed to execute their functions. This process of making the protein competent is achieved through specific post translational modifications (PTMs). The star of the PTMs is a cellular process called phosphorylation. The conventional methods adopted for quantifying phosphorylation are highly labor intensive. The development of phospho-specific antibodies has allowed for a huge sigh of relief from researchers due to their reputation of being quick, and detecting only phosphorylated forms of proteins in a complex mixture of phosphorylated and non-phosphorylated forms.

 

A Closer Look at the Fundamentals of Recombinant DNA Technology

Posted by Bryent Lee on Oct 27, 2020 4:09:38 PM

The advancement of recombinant DNA technology in recent years has drastically changed the world of research by controlling the expressions of target genes. Recombinant DNA combines genetic material from different sources, creating sequences that are unique and new to the genome. The DNA sequences used in the construction of recombinant DNA molecules can originate from any species, such as human, fungal, bacterial, and plants. 1